167 related articles for article (PubMed ID: 18204431)
1. Immunostaining for peroxisome proliferator gamma distinguishes dedifferentiated liposarcoma from other retroperitoneal sarcomas.
Horvai AE; Schaefer JT; Nakakura EK; O'Donnell RJ
Mod Pathol; 2008 May; 21(5):517-24. PubMed ID: 18204431
[TBL] [Abstract][Full Text] [Related]
2. Overlapping features between dedifferentiated liposarcoma and undifferentiated high-grade pleomorphic sarcoma.
Chung L; Lau SK; Jiang Z; Loera S; Bedel V; Ji J; Weiss LM; Chu PG
Am J Surg Pathol; 2009 Nov; 33(11):1594-600. PubMed ID: 19574885
[TBL] [Abstract][Full Text] [Related]
3. p16 Immunohistochemistry is Less Useful Than MDM2 and CDK4 to Distinguish Dedifferentiated Liposarcomas From Other Retroperitoneal Mimics.
Kang Y; Horvai AE
Appl Immunohistochem Mol Morphol; 2017 Jan; 25(1):58-63. PubMed ID: 26509911
[TBL] [Abstract][Full Text] [Related]
4. Similarity in genetic alterations between paired well-differentiated and dedifferentiated components of dedifferentiated liposarcoma.
Horvai AE; DeVries S; Roy R; O'Donnell RJ; Waldman F
Mod Pathol; 2009 Nov; 22(11):1477-88. PubMed ID: 19734852
[TBL] [Abstract][Full Text] [Related]
5. Dedifferentiated liposarcoma with "homologous" lipoblastic (pleomorphic liposarcoma-like) differentiation: clinicopathologic and molecular analysis of a series suggesting revised diagnostic criteria.
Mariño-Enríquez A; Fletcher CD; Dal Cin P; Hornick JL
Am J Surg Pathol; 2010 Aug; 34(8):1122-31. PubMed ID: 20588177
[TBL] [Abstract][Full Text] [Related]
6. Comparison between retroperitoneal leiomyosarcoma and dedifferentiated liposarcoma.
Ishii T; Kohashi K; Ootsuka H; Iura K; Maekawa A; Yamada Y; Bekki H; Yoshimoto M; Yamamoto H; Iwamoto Y; Oda Y
Pathol Res Pract; 2017 Jun; 213(6):634-638. PubMed ID: 28552535
[TBL] [Abstract][Full Text] [Related]
7. Most malignant fibrous histiocytomas developed in the retroperitoneum are dedifferentiated liposarcomas: a review of 25 cases initially diagnosed as malignant fibrous histiocytoma.
Coindre JM; Mariani O; Chibon F; Mairal A; De Saint Aubain Somerhausen N; Favre-Guillevin E; Bui NB; Stoeckle E; Hostein I; Aurias A
Mod Pathol; 2003 Mar; 16(3):256-62. PubMed ID: 12640106
[TBL] [Abstract][Full Text] [Related]
8. Application of MDM2 Fluorescence In Situ Hybridization and Immunohistochemistry in Distinguishing Dedifferentiated Liposarcoma From Other High-grade Sarcomas.
Song MJ; Cho KJ; Lee JS; Song JS
Appl Immunohistochem Mol Morphol; 2017; 25(10):712-719. PubMed ID: 27028243
[TBL] [Abstract][Full Text] [Related]
9. Dedifferentiated liposarcomas with divergent myosarcomatous differentiation developed in the internal trunk: a study of 27 cases and comparison to conventional dedifferentiated liposarcomas and leiomyosarcomas.
Binh MB; Guillou L; Hostein I; Château MC; Collin F; Aurias A; Binh BN; Stoeckle E; Coindre JM
Am J Surg Pathol; 2007 Oct; 31(10):1557-66. PubMed ID: 17895758
[TBL] [Abstract][Full Text] [Related]
10. Can HMGI-C be used as an aid with MDM2 and CDK4 to differentiate liposarcoma subtypes from their mimics?
Alshenawy H
J Cancer Res Clin Oncol; 2013 Jun; 139(6):1073-81. PubMed ID: 23529275
[TBL] [Abstract][Full Text] [Related]
11. Retroperitoneal Well-Differentiated Liposarcoma With Uterine-Type Leiomyomatous Differentiation: A First Case Report With Literature Analysis of Soft Tissue Sarcomas With Dual Lipomatous and Low-Grade Smooth Muscle Differentiation.
Tran TAN; de La Fuente S
Int J Surg Pathol; 2019 Oct; 27(7):798-803. PubMed ID: 31131653
[TBL] [Abstract][Full Text] [Related]
12. Differential diagnosis of atypical lipomatous tumor/well-differentiated liposarcoma and dedifferentiated liposarcoma: utility of p16 in combination with MDM2 and CDK4 immunohistochemistry.
Kammerer-Jacquet SF; Thierry S; Cabillic F; Lannes M; Burtin F; Henno S; Dugay F; Bouzillé G; Rioux-Leclercq N; Belaud-Rotureau MA; Stock N
Hum Pathol; 2017 Jan; 59():34-40. PubMed ID: 27597521
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic Utility and Limitations of Immunohistochemistry of p16, CDK4, and MDM2 and Automated Dual-color In Situ Hybridization of MDM2 for the Diagnosis of Challenging Cases of Dedifferentiated Liposarcoma.
Kobayashi A; Sakuma T; Fujimoto M; Jimbo N; Hirose T
Appl Immunohistochem Mol Morphol; 2019; 27(10):758-763. PubMed ID: 31145104
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory malignant fibrous histiocytomas and dedifferentiated liposarcomas: histological review, genomic profile, and MDM2 and CDK4 status favour a single entity.
Coindre JM; Hostein I; Maire G; Derré J; Guillou L; Leroux A; Ghnassia JP; Collin F; Pedeutour F; Aurias A
J Pathol; 2004 Jul; 203(3):822-30. PubMed ID: 15221942
[TBL] [Abstract][Full Text] [Related]
15. Retroperitoneal liposarcomas: follow-up analysis of dedifferentiation after clinicopathologic reexamination of 86 liposarcomas and malignant fibrous histiocytomas.
Fabre-Guillevin E; Coindre JM; Somerhausen Nde S; Bonichon F; Stoeckle E; Bui NB
Cancer; 2006 Jun; 106(12):2725-33. PubMed ID: 16688768
[TBL] [Abstract][Full Text] [Related]
16. Expanding the differential of cutaneous epithelioid tumors: A case of dedifferentiated liposarcoma with epithelioid features involving the skin, with review of the literature.
Chambers M; Badin DJ; Sriharan AA; Linos KD
J Cutan Pathol; 2020 Jun; 47(6):554-560. PubMed ID: 31995237
[TBL] [Abstract][Full Text] [Related]
17. Are peripheral purely undifferentiated pleomorphic sarcomas with MDM2 amplification dedifferentiated liposarcomas?
Le Guellec S; Chibon F; Ouali M; Perot G; Decouvelaere AV; Robin YM; Larousserie F; Terrier P; Coindre JM; Neuville A
Am J Surg Pathol; 2014 Mar; 38(3):293-304. PubMed ID: 24525499
[TBL] [Abstract][Full Text] [Related]
18. Dedifferentiated Liposarcoma Mimicking a Primary Colon Mass.
Hollowoa B; Lamps LW; Mizell JS; English GW; Bridge JA; Ram R; Gardner JM
Int J Surg Pathol; 2018 Apr; 26(2):174-179. PubMed ID: 28950740
[TBL] [Abstract][Full Text] [Related]
19. [A case of retroperitoneal dedifferentiated liposarcoma initially diagnosed as malignant fibrous histiocytoma: a case report].
Nishizawa K; Kanno T; Takahashi T; Nishiyama H; Ito A; Ito N; Yamamoto S; Kamoto T; Ogawa O; Kotani H; Adachi Y; Sakurai T; Manabe T
Hinyokika Kiyo; 2006 Jan; 52(1):11-4. PubMed ID: 16479982
[TBL] [Abstract][Full Text] [Related]
20. MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes: a comparative analysis of 559 soft tissue neoplasms with genetic data.
Binh MB; Sastre-Garau X; Guillou L; de Pinieux G; Terrier P; Lagacé R; Aurias A; Hostein I; Coindre JM
Am J Surg Pathol; 2005 Oct; 29(10):1340-7. PubMed ID: 16160477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
